The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence BPC 157: Experimental Peptide Creates Risk for Athletes RFK Jr. and the Perils of Peptides Washington Monthly BPC 157: Miracle Healing Peptide or Hidden Danger? FDA's Overreach on Compounded Peptides